Biden Announces ‘Monumental’ Marijuana Rescheduling, DOJ To Take Next Steps
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. Cannabis stocks rise.
Cannabis Cultivation Solutions Provider Agrify And California’s Nature’s Miracle Sign Definitive Merger Deal
Vertical farming technology and infrastructure provider Nature's Miracle Holding Inc. (NASDAQ: NMHI) and Agrify Corporation (NASDAQ: AGFY) announced on Thursday that both parties have signed a definitive agreement and plan of merger. Under the deal, a new wholly-owned subsidiary of Nature's Miracle will merge with and into Agrify, with Agrify surviving the merger as a wholly-owned subsidiary of Nature's Miracle. The signing of the definitive agreement directly follows the previously announced term sheet for the merger, according to a press release.
‘Psychedelics-Inspired’ Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe the first quarter of 2024 was a highly productive period for Enveric as the company continued to advance the development of the lead neuroplastogen drug candidate, EB-003, in preparation for an investigational new drug (IND) application and the expected initiation of a planned clinical development program," Joseph Tucker, Ph.D., director and CEO of Enveric, said. "EB-003 was designed specifically to address this major safety profile deficiency in the first-generation psychedelic approach to treating neuropsychiatric illness, and we are excited to advance its development."
Pitch Your Cannabis Business And Win Thousands In Prizes At This Benzinga & Curaleaf Competition
The Benzinga Cannabis Capital Conference, in partnership with Curaleaf's (OTC: CURLF) corporate philanthropy arm, Rooted In Good, has launched the
Blüm Holdings Q1 Revenue Drop 16% YoY, Eliminates Non-Performing Legacy Operations, Reduces Net Loss
Blüm Holdings, Inc. (OTCQB:BLMH) reported its financial results Wednesday for the first quarter ended March 31, 2024, revealing revenue of $6.78 million,…
Canadian Marijuana Company Rubicon Organics Reports Flat Revenue, Adjusted EBITDA Loss, Provides Positive Outlook
Rubicon Organics Inc. (TSXV:ROMJ) (OTCQX:ROMJF) reported its financial results Wednesday for the first quarter ended March 31, 2024,…
TILT Holdings Q1 Revenue Down, Net Loss Up Due To Lower Prices, Optimistic On Rescheduling, Plans To Address Debt
TILT Holdings (CBOE: TILT) (OTCQB:TLLTF), reported financial and operating results for the first quarter that ended March 31, 2024, with…
Delta 9 Cannabis’ Q1 Revenue Drops Slightly YoY, Gross Profit Grows 10%
Delta 9 Cannabis Inc. announced on Wednesday financial and operating results for the three months ending March 31, 2024."During the first quarter, we continued to focus on sustaining revenues across our core business units while optimizing our margins," John Arbuthnot, CEO of Delta 9, said. "We will continue our relentless focus on cost and operational efficiencies and strengthening our balance sheet to deliver sustained, profitable growth for our shareholders
Cannabis-Focused Software Co. Springbig Sees Slight Q1 Revenue Decline But Improves Net Loss, Keeps Full Year Financial Guidance
Paul Sykes, CFO, remarked on achieving a positive adjusted EBITDA for the first time at $0.2 million, compared to a loss of $1.3M last year
Schwazze’s Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%
Medicine Man Technologies, Inc., operating as Schwazze (OTC: SHWZ), announced its financial results for the first quarter ended March 31, 2024.